A zero-dose synthetic baseline for the personalized analysis of [(18)F]FDG-PET: Application in Alzheimer’s disease

PURPOSE: Brain 2-Deoxy-2-[(18)F]fluoroglucose ([(18)F]FDG-PET) is widely used in the diagnostic workup of Alzheimer’s disease (AD). Current tools for uptake analysis rely on non-personalized templates, which poses a challenge as decreased glucose uptake could reflect neuronal dysfunction, or heterog...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinge, Christian, Henriksen, Otto Mølby, Lindberg, Ulrich, Hasselbalch, Steen Gregers, Højgaard, Liselotte, Law, Ian, Andersen, Flemming Littrup, Ladefoged, Claes Nøhr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749397/
https://www.ncbi.nlm.nih.gov/pubmed/36532287
http://dx.doi.org/10.3389/fnins.2022.1053783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749397/
https://www.ncbi.nlm.nih.gov/pubmed/36532287
http://dx.doi.org/10.3389/fnins.2022.1053783

Ejemplares similares